KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Receivables (2020 - 2025)

Oscar Health (OSCR) has disclosed Receivables for 6 consecutive years, with $442.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 40.13% year-over-year to $442.6 million, compared with a TTM value of $442.6 million through Dec 2025, up 40.13%, and an annual FY2025 reading of $442.6 million, up 40.13% over the prior year.
  • Receivables was $442.6 million for Q4 2025 at Oscar Health, down from $445.5 million in the prior quarter.
  • Across five years, Receivables topped out at $488.8 million in Q1 2025 and bottomed at $75.9 million in Q1 2021.
  • Average Receivables over 5 years is $258.4 million, with a median of $211.3 million recorded in 2022.
  • The sharpest move saw Receivables skyrocketed 111.89% in 2021, then dropped 7.02% in 2023.
  • Year by year, Receivables stood at $138.4 million in 2021, then soared by 56.4% to $216.5 million in 2022, then decreased by 7.02% to $201.3 million in 2023, then surged by 56.95% to $315.9 million in 2024, then surged by 40.13% to $442.6 million in 2025.
  • Business Quant data shows Receivables for OSCR at $442.6 million in Q4 2025, $445.5 million in Q3 2025, and $465.4 million in Q2 2025.